A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients-Reference-Cited by-同舟云学术

A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients

Published:2021-07-07 Issue:8 Volume:15 Page:929-939
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Hirschfield Gideon M¹,Chazouillères Olivier²,Cortez-Pinto Helena³,Macedo Guilherme⁴,de Lédinghen Victor⁵,Adekunle Femi⁶,Carbone Marco⁷

Affiliation:

1. Toronto Centre for Liver Diseases, University Health Network and University of Toronto, Toronto, Canada

2. Assistance Publique - Hôpitaux De Paris (APHP), Reference Centre for Inflammatory Biliary Diseases and Autoimmune Hepatitis (CRMR, MIVB-H), Department of Hepatology Saint-Antoine Hospital, Sorbonne Université, INSERM, Saint-Antoine Research Center, Paris, France

3. Clínica Universitária De Gastrenterologia, Faculdade De Medicina, Universidade De Lisboa, Lisbon, Portugal

4. Gastroenterology and Hepatology Department, Centro Hospitalar São João, Porto, Portugal

5. Hepatology Unit, Bordeaux University Hospital, Pessac, & INSERM U1053, Bordeaux University, Bordeaux, France

6. Intercept Pharmaceuticals, Europe Ltd. London, UK

7. Division of Gastroenterology, Centre for Autoimmune Liver Disease, University of Milan-Bicocca, Milan, Italy

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2021.1945919

Reference18 articles.

1. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

2. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines

3. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis

4. European Medicine Agency (EMA). OCALIVA. obeticholic acid. 2019. online. [cited 2019 Feb 12]. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/ocaliva

5. Evolving role of obeticholic acid in primary biliary cholangitis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis;Digestive and Liver Disease;2024-09

2. Pruritus, Fatigue, Osteoporosis and Dyslipoproteinemia in Pbc Patients: A Clinician’s Perspective;Gastroenterology Insights;2024-05-17

3. Extrahepatic conditions of primary biliary cholangitis: A systematic review and meta-analysis of prevalence and risk;Clinics and Research in Hepatology and Gastroenterology;2024-05

4. A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score;European Journal of Gastroenterology & Hepatology;2024-03-25

5. Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis;International Journal of Molecular Sciences;2024-01-22